Sale!

ABL Gene Load Test Cost

Original price was: 1,200 د.إ.Current price is: 900 د.إ.

-25%

The ABL Gene Load Test is a specialized diagnostic procedure aimed at detecting and quantifying the BCR-ABL fusion gene, which is a hallmark of certain types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This test is particularly crucial for monitoring disease progression and response to therapy in patients diagnosed with these conditions. By accurately measuring the amount of BCR-ABL gene transcripts present in a patient’s blood or bone marrow, healthcare providers can tailor treatment strategies more effectively and predict patient outcomes with greater precision.

At DNA Labs UAE, the ABL Gene Load Test is offered for a cost of 900 AED. The lab utilizes state-of-the-art technology and methodologies to ensure accurate and reliable results. DNA Labs UAE is renowned for its commitment to quality and precision in genetic testing, making it a trusted choice for patients and healthcare professionals alike. The test is conducted by highly trained specialists who follow stringent protocols to ensure the integrity of the samples and the accuracy of the test results. Patients opting for this test at DNA Labs UAE can expect professional service and comprehensive support throughout the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ABL Gene Load Test Cost AED:900.0

Are you looking for information on the ABL Gene Load Test? Look no further! DNA Labs UAE offers the ABL Gene Load Test at a cost of AED 900.0. Read on to learn more about the test components, sample condition, report delivery, and more.

Test Name: ABL Gene Load Test

Components: Whole Blood, Culture Cells

Price: 900.0 AED

Sample Condition: Whole Blood, Culture Cells

Report Delivery: 3rd Working Day Email: 36 hours. On phone: 24 hours

Method: Real Time PCR

Test Type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Before undergoing the ABL Gene Load Test, patients need to sign a consent document and bring any clinical history related to the test.

What is the ABL Gene Load Test?

The ABL gene load test is a diagnostic test used to determine the amount or level of the ABL gene in a sample. The ABL gene codes for a protein called Abelson tyrosine kinase, which plays a role in cell signaling and regulation.

This test is commonly used in the field of oncology to monitor and assess the response to treatment in patients with chronic myeloid leukemia (CML). In CML, there is a specific chromosomal abnormality known as the Philadelphia chromosome, which causes the fusion of the ABL gene with another gene called BCR. This fusion gene, called BCR-ABL, produces a protein with abnormal tyrosine kinase activity that promotes the growth and survival of cancer cells.

How is the ABL Gene Load Test performed?

The ABL gene load test is typically performed using a technique called quantitative reverse transcription polymerase chain reaction (qRT-PCR). This involves converting the RNA molecules produced by the BCR-ABL fusion gene into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR, and the amount of amplified cDNA is quantified.

The results of the ABL gene load test are reported as a ratio of BCR-ABL transcripts to a control gene, such as the ABL gene itself or another reference gene. This ratio is compared to a standardized baseline or threshold to determine the level of BCR-ABL expression. A lower ratio indicates a lower disease burden and a better response to treatment, while a higher ratio indicates a higher disease burden and a poorer response to treatment.

Benefits of the ABL Gene Load Test

The ABL gene load test is a valuable tool in monitoring and managing CML patients. It provides important information about the disease progression and treatment response, helping healthcare professionals make informed decisions regarding treatment adjustments. Additionally, the test can also be used to detect early signs of relapse.

Don’t wait any longer! Contact DNA Labs UAE today to schedule your ABL Gene Load Test and gain valuable insights into your condition.

Test Name ABL Gene Load Test
Components
Price 900.0 AED
Sample Condition Whole Blood, Culture Cells
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forABL Gene Load Test
Test Details

The ABL gene load test is a diagnostic test used to determine the amount or level of the ABL gene in a sample. The ABL gene is a gene that codes for a protein called Abelson tyrosine kinase, which is involved in cell signaling and regulation.

This test is commonly used in the field of oncology to monitor and assess the response to treatment in patients with chronic myeloid leukemia (CML). In CML, there is a specific chromosomal abnormality called the Philadelphia chromosome, which results in the fusion of the ABL gene with another gene called BCR. This fusion gene, known as BCR-ABL, produces a protein with abnormal tyrosine kinase activity that promotes the growth and survival of cancer cells.

The ABL gene load test measures the quantity of BCR-ABL transcripts, which are the RNA molecules produced by the BCR-ABL fusion gene. By quantifying the BCR-ABL transcripts, the test can provide information about the disease burden and response to treatment in CML patients.

The ABL gene load test is typically performed using a technique called quantitative reverse transcription polymerase chain reaction (qRT-PCR). This technique involves converting the RNA molecules into complementary DNA (cDNA) using reverse transcription, and then amplifying the cDNA using PCR. The amount of amplified cDNA is then quantified, which reflects the level of BCR-ABL transcripts in the sample.

The results of the ABL gene load test are reported as a ratio of BCR-ABL transcripts to a control gene, such as the ABL gene itself or another reference gene. This ratio is then compared to a standardized baseline or threshold to determine the level of BCR-ABL expression. A lower ratio indicates a lower disease burden and a better response to treatment, while a higher ratio indicates a higher disease burden and a poorer response to treatment.

Overall, the ABL gene load test is a valuable tool in monitoring and managing CML patients, as it provides important information about the disease progression and treatment response. It helps healthcare professionals make informed decisions regarding treatment adjustments and can also be used to detect early signs of relapse.